Travis S Johnson (Travis Johnson)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Benign Prostatic Hyperplasia

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Nature communications

Genome medicine

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Gitanjali Roy, Rameesha Syed, Olivia Lazaro, Sylvia Robertson, Sean D McCabe, Daniela Rodriguez, Alex M Mawla, Travis S Johnson, Michael A Kalwat
Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning. bioRxiv : the preprint server for biology (2024)
Travis S Johnson, Parvathi Sudha, Enze Liu, Nathan Becker, Sylvia Robertson, Patrick Blaney, Gareth J Morgan, Vivek S Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A Walker
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Nature communications 15 (1) (2024)
Brian A Walker, Travis S Johnson, Parvathi Sudha, Enze Liu, Patrick Blaney, Gareth J Morgan, Vivek Chopra, Cedric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma. Research square (2023)
Lujain Alsaleh, Chen Li, Justin L Couetil, Ze Ye, Kun Huang, Jie Zhang, Chao Chen, Travis S Johnson
Spatial Transcriptomic Analysis Reveals Associations between Genes and Cellular Topology in Breast and Prostate Cancers. Cancers 14 (19) (2022)
Yusong Liu, Tongxin Wang, Ben Duggan, Michael Sharpnack, Kun Huang, Jie Zhang, Xiufen Ye, Travis S Johnson
SPCS: a spatial and pattern combined smoothing method for spatial transcriptomic expression. Briefings in bioinformatics 23 (3) (2022)
Travis S Johnson, Christina Y Yu, Zhi Huang, Siwen Xu, Tongxin Wang, Chuanpeng Dong, Wei Shao, Mohammad Abu Zaid, Xiaoqing Huang, Yijie Wang, Christopher Bartlett, Yan Zhang, Brian A Walker, Yunlong Liu, Kun Huang, Jie Zhang
Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease. Genome medicine 14 (1) (2022)
Elham Jafari, Travis S Johnson, Yue Wang, Yunlong Liu, Kun Huang, Yijie Wang
AIscEA: unsupervised integration of single-cell gene expression and chromatin accessibility via their biological consistency. Bioinformatics (Oxford, England) 38 (23) (2022)